Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2003;52:8-9; doi:10.1136/gut.52.1.8
Copyright © 2003 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 2003;52:8-9
© 2003 by Gut

COMMENTARY

Cancer

A rat virus visits the clinic: translating basic discoveries into clinical medicine in the 21st century

C R Boland, A Goel

Department of Medicine and Comprehensive Cancer Center, University of California San Diego, La Jolla, CA, USA

Correspondence to:
Correspondence to:
Dr C R Boland, 4028 Basic Science Building, University of California San Diego, 9500 Gilman Drive, San Diego, CA 92093-0688, USA;
crboland@ucsd.edu


Mutant forms of the KRAS2 gene are present in the serum of patients who have undergone putatively curative surgery for colorectal cancer and may be used to guide novel therapies in the future by identifying those individuals at greatest risk of recurrence

Keywords: DNA; KRAS2; KRAS2 mutation; prognosis; colorectal carcinoma

The first 150 words of the full text of this article appear below.

One of the holy grails of biomedical research is to identify markers of occult disease that might lead to early treatment of that disease before the manifestations are overt—and ipso facto incurable. In this issue of Gut, Ryan and colleagues1 from Dublin report that one more application of basic science discovery might be ready for use in the management of patients with colorectal cancer [see page 101]. These investigators have found that mutant forms of the KRAS2 gene are present in the serum of patients who have undergone putatively curative surgery for colorectal cancer. This information can predict tumour recurrences and, by inference, might be used to guide novel therapies in the future by identifying those individuals at greatest risk of recurrence. We have all waited patiently for the fruits of the molecular biology revolution that began nearly two decades ago, and it may be worthwhile . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher
Gut 2003 52: 101-108. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs